Peter Guenter

Director/Board Member at IPSEN

Net worth: 15 019 $ as of 2026-06-29

63 year

69 connections

Health Technology

Consumer Services

Commercial Services

Profile

Peter Guenter is currently Director at Ipsen SA since 2026, Director at Vicore Pharma Holding AB since 2026, and Director at the European Federation of Pharmaceutical Industries & Assns.
Formerly, Mr. Guenter was Chief Executive Officer & Director at Almirall SA from 2017 to 2020, Member-Management Board & CEO-Healthcare at Merck KGaA from 2021 to 2025, Chief Executive Officer at Merck Healthcare KGaA, Chairman-Supervisory Board at Sanofi-Aventis Deutschland GmbH, Independent Non-Executive Director at Lakefront Biotherapeutics from 2019 to 2025, EVP, General Manager-Diabetes & Cardiovascular at Sanofi from 2013 to 2017, and Executive Vice President at Smithkline Beecham.
Education includes graduation from Ghent University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
LAKEFRONT BIOTHERAPEUTICS 0%	2025-12-30	501 ( 0% )	15 019 $	2026-06-29

Peter Guenter active positions

Companies	Position	Start
IPSEN	Director/Board Member	2026-01-27
VICORE PHARMA HOLDING AB	Director/Board Member	2026-05-06
European Federation of Pharmaceutical Industries & Assns European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development	Director/Board Member	-

All active positions of Peter Guenter

Former positions of Peter Guenter

Companies	Position	End
LAKEFRONT BIOTHERAPEUTICS NV	Director/Board Member	2025-07-27
MERCK KGAA	Corporate Officer/Principal	2025-05-31
ALMIRALL, S.A.	Chief Executive Officer	2020-12-30
SANOFI	Corporate Officer/Principal	2017-07-31
Merck Healthcare KGaA Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients	Chief Executive Officer	-

See the detail of Peter Guenter's experience

Training of Peter Guenter

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Guenter's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Merck KGaA Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products	Health Technology
Sanofi Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines	Health Technology
Ipsen SA Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Galapagos NV Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology	Health Technology
Almirall SA Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals	Health Technology
Ghent University Ghent University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services	Health Technology
European Federation of Pharmaceutical Industries & Assns European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development	Commercial Services
Smithkline Beecham
Vicore Pharma Holding AB Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases	Health Technology
Merck Healthcare KGaA Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients	Health Technology